Non-alcoholic Fatty Liver Disease : : New Insight and Glance Into Disease Pathogenesis / / edited by Ju-Seop Kang.
Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis that develops in the absence of competing for liver disease etiologies such as alcohol consumption, monogenic hereditary conditions, or iatrogenic causes. The pathogenesis of NAFLD is multifactorial and its understanding...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | London : : IntechOpen,, 2023. ©2023 |
Year of Publication: | 2023 |
Language: | English |
Physical Description: | 1 online resource (ix, 156 pages) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993581460804498 |
---|---|
ctrlnum |
(CKB)5680000000300265 (NjHacI)995680000000300265 (EXLCZ)995680000000300265 |
collection |
bib_alma |
record_format |
marc |
spelling |
Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / edited by Ju-Seop Kang. Non-alcoholic Fatty Liver Disease London : IntechOpen, 2023. ©2023 1 online resource (ix, 156 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis that develops in the absence of competing for liver disease etiologies such as alcohol consumption, monogenic hereditary conditions, or iatrogenic causes. The pathogenesis of NAFLD is multifactorial and its understanding is still incomplete. Although knowledge of the cellular and molecular mechanisms underlying disease development and progression has grown significantly in recent years, the exact contribution of environmental and genetic factors as well as that of extrahepatic and intrahepatic events in determining the disease phenotype remains ill defined. This book discusses topics highly correlated with NAFLD such as the regulation of iron metabolism, the role of the enzyme heparanase in liver steatosis, transcriptional regulation by ERR and its role in pathogenesis, hepatic lipid homeostasis, therapeutic approaches to NAFLD, and pathogenesis and significance of HDL as a molecular modifier in NAFLD. Preface -- Section 1 Basic Concept and Molecular Aspect in the Development of NAFLD/NASH -- Chapter 1 Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier by Ibrahim Kalle Kwaifa, Abdullahi S. Mainasara, Muhammad Lawal Jidda, Amrina Mohammad Amin, Garba Abdullahi, Faruku Ladan and Maryam Danyaro -- Chapter 2 Hepatic Lipid Homeostasis in NAFLD by Shuo Zhang, Bing Ji, Changqing Yang and Li Yang -- Chapter 3 Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis by Brittney Hua, Ielyzaveta Slarve, Aditi A. Datta, Chenxi Xu, Chien-yu Chen and Bangyan L. Stiles -- Section 2 Therapeutic Aspect Including Iron Metabolism and Heparinase in NAFLD -- Chapter 4 Role of the Enzyme Heparanase in the Development of Fatty Liver by Shadi Hamoud -- Chapter 5 Regulation of Iron Metabolism in NAFLD/NASH by Yuki Hamada and Eiichi Hirano -- Chapter 6 Therapeutic Approach to NAFLD-NASH by Georgios Sfikas and Ioannis Valsamidis. Fatty liver. 1-83968-090-3 1-83968-091-1 Kang, Ju-Seop, editor. |
language |
English |
format |
eBook |
author2 |
Kang, Ju-Seop, |
author_facet |
Kang, Ju-Seop, |
author2_variant |
j s k jsk |
author2_role |
TeilnehmendeR |
title |
Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / |
spellingShingle |
Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / Preface -- Section 1 Basic Concept and Molecular Aspect in the Development of NAFLD/NASH -- Chapter 1 Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier by Ibrahim Kalle Kwaifa, Abdullahi S. Mainasara, Muhammad Lawal Jidda, Amrina Mohammad Amin, Garba Abdullahi, Faruku Ladan and Maryam Danyaro -- Chapter 2 Hepatic Lipid Homeostasis in NAFLD by Shuo Zhang, Bing Ji, Changqing Yang and Li Yang -- Chapter 3 Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis by Brittney Hua, Ielyzaveta Slarve, Aditi A. Datta, Chenxi Xu, Chien-yu Chen and Bangyan L. Stiles -- Section 2 Therapeutic Aspect Including Iron Metabolism and Heparinase in NAFLD -- Chapter 4 Role of the Enzyme Heparanase in the Development of Fatty Liver by Shadi Hamoud -- Chapter 5 Regulation of Iron Metabolism in NAFLD/NASH by Yuki Hamada and Eiichi Hirano -- Chapter 6 Therapeutic Approach to NAFLD-NASH by Georgios Sfikas and Ioannis Valsamidis. |
title_sub |
New Insight and Glance Into Disease Pathogenesis / |
title_full |
Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / edited by Ju-Seop Kang. |
title_fullStr |
Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / edited by Ju-Seop Kang. |
title_full_unstemmed |
Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / edited by Ju-Seop Kang. |
title_auth |
Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / |
title_alt |
Non-alcoholic Fatty Liver Disease |
title_new |
Non-alcoholic Fatty Liver Disease : |
title_sort |
non-alcoholic fatty liver disease : new insight and glance into disease pathogenesis / |
publisher |
IntechOpen, |
publishDate |
2023 |
physical |
1 online resource (ix, 156 pages) : illustrations |
contents |
Preface -- Section 1 Basic Concept and Molecular Aspect in the Development of NAFLD/NASH -- Chapter 1 Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier by Ibrahim Kalle Kwaifa, Abdullahi S. Mainasara, Muhammad Lawal Jidda, Amrina Mohammad Amin, Garba Abdullahi, Faruku Ladan and Maryam Danyaro -- Chapter 2 Hepatic Lipid Homeostasis in NAFLD by Shuo Zhang, Bing Ji, Changqing Yang and Li Yang -- Chapter 3 Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis by Brittney Hua, Ielyzaveta Slarve, Aditi A. Datta, Chenxi Xu, Chien-yu Chen and Bangyan L. Stiles -- Section 2 Therapeutic Aspect Including Iron Metabolism and Heparinase in NAFLD -- Chapter 4 Role of the Enzyme Heparanase in the Development of Fatty Liver by Shadi Hamoud -- Chapter 5 Regulation of Iron Metabolism in NAFLD/NASH by Yuki Hamada and Eiichi Hirano -- Chapter 6 Therapeutic Approach to NAFLD-NASH by Georgios Sfikas and Ioannis Valsamidis. |
isbn |
1-83968-090-3 1-83968-091-1 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC848 |
callnumber-sort |
RC 3848 F3 N663 42023 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.362 |
dewey-sort |
3616.362 |
dewey-raw |
616.362 |
dewey-search |
616.362 |
work_keys_str_mv |
AT kangjuseop nonalcoholicfattyliverdiseasenewinsightandglanceintodiseasepathogenesis AT kangjuseop nonalcoholicfattyliverdisease |
status_str |
n |
ids_txt_mv |
(CKB)5680000000300265 (NjHacI)995680000000300265 (EXLCZ)995680000000300265 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1764995748507680768 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02964nam a2200301 i 4500</leader><controlfield tag="001">993581460804498</controlfield><controlfield tag="005">20230328022920.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230328s2023 enka o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5680000000300265</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995680000000300265</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995680000000300265</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC848.F3</subfield><subfield code="b">.N663 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.362</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Non-alcoholic Fatty Liver Disease :</subfield><subfield code="b">New Insight and Glance Into Disease Pathogenesis /</subfield><subfield code="c">edited by Ju-Seop Kang.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Non-alcoholic Fatty Liver Disease </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (ix, 156 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis that develops in the absence of competing for liver disease etiologies such as alcohol consumption, monogenic hereditary conditions, or iatrogenic causes. The pathogenesis of NAFLD is multifactorial and its understanding is still incomplete. Although knowledge of the cellular and molecular mechanisms underlying disease development and progression has grown significantly in recent years, the exact contribution of environmental and genetic factors as well as that of extrahepatic and intrahepatic events in determining the disease phenotype remains ill defined. This book discusses topics highly correlated with NAFLD such as the regulation of iron metabolism, the role of the enzyme heparanase in liver steatosis, transcriptional regulation by ERR and its role in pathogenesis, hepatic lipid homeostasis, therapeutic approaches to NAFLD, and pathogenesis and significance of HDL as a molecular modifier in NAFLD.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Preface -- Section 1 Basic Concept and Molecular Aspect in the Development of NAFLD/NASH -- Chapter 1 Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier by Ibrahim Kalle Kwaifa, Abdullahi S. Mainasara, Muhammad Lawal Jidda, Amrina Mohammad Amin, Garba Abdullahi, Faruku Ladan and Maryam Danyaro -- Chapter 2 Hepatic Lipid Homeostasis in NAFLD by Shuo Zhang, Bing Ji, Changqing Yang and Li Yang -- Chapter 3 Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis by Brittney Hua, Ielyzaveta Slarve, Aditi A. Datta, Chenxi Xu, Chien-yu Chen and Bangyan L. Stiles -- Section 2 Therapeutic Aspect Including Iron Metabolism and Heparinase in NAFLD -- Chapter 4 Role of the Enzyme Heparanase in the Development of Fatty Liver by Shadi Hamoud -- Chapter 5 Regulation of Iron Metabolism in NAFLD/NASH by Yuki Hamada and Eiichi Hirano -- Chapter 6 Therapeutic Approach to NAFLD-NASH by Georgios Sfikas and Ioannis Valsamidis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Fatty liver.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83968-090-3</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83968-091-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kang, Ju-Seop,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 13:28:01 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-02-11 21:29:23 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5343026330004498&Force_direct=true</subfield><subfield code="Z">5343026330004498</subfield><subfield code="8">5343026330004498</subfield></datafield></record></collection> |